Cardiovascular Trials Review Cardiovascular Trials Review - Diegori.it

Page
Acronym/Title
Contents
176 ESCAMI – Evaluation of the Safety and Cardioprotective Effects of
Eniporide in Acute Myocardial Infarction
179 Does Angina Pectoris the Week Before Protect Against First Acute
Myocardial Infarction in Patients with Diabetes Mellitus
181 HALT-MI – Hu23F2G Anti-Adhesion to Limit Cytotoxic Injury
Following AMI
184 MAGIC – Magnesium in Coronaries
186 FLORIDA – Fluvastatin on Risk Diminishment After Acute Myocardial
Infarction
189 SADHART – Sertraline Antidepressant Heart Attack Randomized Trial
2. Acute Treatment of Stroke
194 NINDS – Neurological Disorders and Stroke Recombinant Tissue
Plasminogen Activator Stroke Study
196 STAT – Stroke Treatment with Ancord Trial
198 ATLANTIS – Alteplase Thrombolysis for Acute Noninterventional
Therapy in Ischemic Stroke
200 PROCAT II – Prolyse in Acute Cerebral Thromboembolism II
203 Aptiganel Hydrochloride in Acute Ischemic Stroke
205 WARSS – Warfarin Aspirin Recurrent Stroke Study
3. Unstable Angina/Non-Q-Wave Infarction/
Non-ST-Elevation Myocardial Infarction or Acute
Coronary Syndrome
208 HASI (Update) – Bivalirudin Angioplasty Study (Hirulog Angioplasty
Study)
211 PRISM-PLUS – Platelet Receptor Inhibition in Ischemic Syndrome
Management in Patients Limited by Unstable Signs and Symptoms
213 PRISM-PLUS (Angiographic Results) – Platelet Receptor Inhibition
for Ischemic Syndrome Management in Patients Limited by Unstable
Signs and Symptoms
215 PRISM-PLUS (Diabetic Substudy) – Platelet Receptor Inhibition in
Ischemic Syndrome Management in Patients Limited by Unstable Signs
and Symptoms
Contents
xi